Antengene To Present One Oral and Four Abstracts at ASCO 202

/PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated...

Related Keywords

China , Chicago , Illinois , United States , Shanghai , Taiwan , Macau , South Korea , Hong Kong , Singapore , Australia , Beijing , Mccormick Place , American , Asia Pacific , Peter Qian , Antengene Corporation Limited , Prnewswire Antengene Corporation Limited , Mccormick Place Convention Center , Hong Kong Stock Exchange , Company Annual , Antengene Corporation , American Society Of Clinical Oncology , Oral Presentation , Corporation Limited , Clinical Oncology , Annual Meeting , Clinical Science Symposium , Stronger Together , Novel Combinations Across , Gynecologic Cancer , Central Daylight Time , Beijing Time , Poster Presentations , Developmental Therapeutics , Bayesian Optimal Interval , Molecularly Targeted Agents , Hematologic Malignancies , Chronic Lymphocytic , Journal Publication , Publication Only , Patients Beyond , Taiwan China , Hong Kong China , Macau China , Annual Report , Hong Kong Stock ,